tetano
Editor, Senior Moderator
Yuen, the chairman for infectious diseases at the University of Hong Kong, said the protease inhibitor Kaletra had been effective in treating severe acute respiratory syndrome (Sars) in 2003.
Along with another drug called interferon beta, it had also worked in laboratory tests on a type of monkey against Middle East respiratory syndrome (Mers), which was first identified in 2012.
“The coronavirus in Sars or the coronavirus in Mers are in the same family of virus with the new coronavirus,” he told a radio programme.
“We can now run tests in laboratories to see if the two drugs are effective in treating the new coronavirus.”
The professor said experts would also explore if adding ribavirin, an antiviral medicine, to those two drugs would improve them.
“We hope we can tell everyone if the drugs are effective in the laboratory after several weeks,” he said.
https://www.scmp.com/news/hong-kong...ina-coronavirus-hong-kong-professor-yuen-kwok
Along with another drug called interferon beta, it had also worked in laboratory tests on a type of monkey against Middle East respiratory syndrome (Mers), which was first identified in 2012.
“The coronavirus in Sars or the coronavirus in Mers are in the same family of virus with the new coronavirus,” he told a radio programme.
“We can now run tests in laboratories to see if the two drugs are effective in treating the new coronavirus.”
The professor said experts would also explore if adding ribavirin, an antiviral medicine, to those two drugs would improve them.
“We hope we can tell everyone if the drugs are effective in the laboratory after several weeks,” he said.
https://www.scmp.com/news/hong-kong...ina-coronavirus-hong-kong-professor-yuen-kwok